Loading clinical trials...

CEFID-I (CEra Flow Improves DVT-1) | Clinical Trials | Clareo Health

COMPLETEDNA

CEFID-I (CEra Flow Improves DVT-1)

A Single Center Clinical Trial to Evaluate the Efficacy and Safety of Blood Circulation Improvement Using an Investigational Medical Device (Model Name CGM MB-1701) for the Risk Group of Deep Vein Thrombosis (DVT) and the Ordinary Person

NCT05469282•Ceragem Clinical Inc.

View on ClinicalTrials.gov

Summary

The study is a single center clinical trial to evaluate the efficacy and safety of blood circulation improvement using an investigational medical device, which is a product on the market and it's name is Ceragem Master V6, for the risk group of Deep Vein Thrombosis (DVT) and the ordinary person. The study compares before and after the application by one time application.

Detailed Description

The efficacy and safety evaluation are conducted before and after (or during) the application of the test device. The investigator shall apply an investigational device once when visiting a suitable subject for one day.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Subjects diagnosed by Doppler ultrasonography as having no blood clots in the femoral vein and the vena poplitea
•2. D-dimer negative test result (Even if the D-dimer test is positive, the subject can be selected through the additional test at the discretion of investigator.)
•3\. Subjects who fully understand the purpose and procedure of the study and wish to participate in clinical trials with voluntary consent
•Additional Inclusion Critetia for the DVT risk subjects;
•1\. Subjects have two or more points of venous thromboembolism (hereinafter referred to as VTE) clinical prediction score (Two-level wells scroe) at the time of screening

Exclusion Criteria

•1. Subjects who complain of a decrease in the sensation of the lower extremities or who is unable to feel the sensation of pain
•2. Subjects who have inflammation or trauma on the skin that directly touches the device

Locations (1)

Presbyterian Medical Center

Jeonju, South Korea

Key Dates

Start Date

August 22, 2022

Primary Completion Date

December 30, 2022

Completion Date

December 30, 2022

Last Updated

February 9, 2026

Enrollment

ACTUAL participants

Conditions

Blood Circulation DisorderDeep Vein Thrombosis

Interventions

Blood circulation device

DEVICE

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

NCT07102160

Deep Vein Thrombosis (DVT)Thrombus in the Peripheral Venous Vasculature+2 more

View study

RECRUITING

Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction Used in Conjunction With Intermittent Pneumatic Compression.

NCT06519435

Deep Vein Thrombosis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CEFID-I (CEra Flow Improves DVT-1)

Inclusion Criteria

Exclusion Criteria

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction Used in Conjunction With Intermittent Pneumatic Compression.

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support

Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb

Early Discovery of Ischemia After Replantation Surgery of the Extremities